Service/Supplier
Filter News
Found 30,489 articles
-
Latest Clinical Evidence Presented at SAWC 2020 Illustrates the Significant Utility of the MolecuLight i:X® for Visualizing Bacteria and Improving Clinical Outcomes
7/31/2020
10 Clinical Posters and Video Presentations Highlight the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Practitioners
-
111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020
7/31/2020
111, Inc., a Company dedicated to digitally connecting patients with drugs and healthcare services in China, announced that it will report its unaudited financial results for the second quarter ended June 30, 2020, before the U.S. market opens on Thursday, August 20, 2020.
-
ABMC Reports First Quarter 2020 Results
7/31/2020
American Bio Medica Corporation announced financial results for the three months ended March 31, 2020.
-
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
7/31/2020
Revive Therapeutics Ltd. is pleased to announce that the U.S. Food & Drug Administration has approved the Company to proceed with a randomized, double-blind, placebo-controlled confirmatory Phase 3 clinical trial protocol to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.
-
Brain Navi Develops New Robot Performing Nasal Swab Tests to Prevent Cross Infections
7/31/2020
Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies.
-
C-RAD: Positive operating income in challenging times
7/31/2020
The ongoing Covid-19 pandemic has continued to play a role in the second quarter, but we managed well.
-
Catalent, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Fiscal Year 2020 Net Revenue, Earnings Before Income Taxes, and Adjusted EBITDA Significantly Ahead of Its Previous Guidance
7/30/2020
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that, given the fluidity created by the COVID-19 pandemic and level of uncertainty at the time when Catalent last provided financial guidance on May 5, 2020, it is providing certain preliminary finan
-
Nuance and Cerner Expand Strategic Voice AI Collaboration to Include Dragon Medical Virtual Assistant Technology
7/30/2020
Cerner selects Nuance's virtual assistant platform to reduce the cognitive burden on care teams and improve patient experience
-
Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results
7/30/2020
Completed acquisition of Progenics Pharmaceuticals, Inc., adding robust portfolio of oncology therapeutics and diagnostics to pipeline
-
BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation
7/30/2020
BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced a sales agent agreement with Boston Scientific, a global medical technology leader.
-
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
7/30/2020
Houston Methodist Research Institute Professor and Chair of the Department of Cardiovascular Sciences Dr. John Cooke and LSU Health Shreveport Vice Chancellor Dr. Alan Kaye Join the JanOne Team
-
Bruker Launches Revolutionary High-Speed AFM System for Single-Molecule Applications
7/30/2020
JPK NanoRacer® Follows Molecular Dynamics in Real Time at 50 Frames per Second
-
Masimo Named NBA Supplier of Pulse Oximetry
7/30/2020
Masimo (NASDAQ: MASI) today announced that it has entered into a partnership with the National Basketball Association (NBA) to be its official supplier of pulse oximetry. As teams return to play, Masimo is supplying the NBA with MightySat ® fingertip pulse oximeters on its campus in Orlando, Florida. This press release features multi
-
Baxter Reports Second-Quarter 2020 Results
7/30/2020
Second-quarter revenue of $2.7 billion decreased 4% on a reported basis, 1% on a constant currency basis and 2% on an operational basis1
-
Compugen Reports Second Quarter 2020 Results
7/30/2020
Initiation of triple combination study accelerating the evaluation of the DNAM axis hypothesis on-track for 2H 2020
-
Codexis to Hold Second Quarter 2020 Conference Call on August 6
7/30/2020
Codexis, Inc., a leading protein engineering company, announces that it will report second quarter 2020 financial results after market close on Thursday, August 6, 2020.
-
Advarra Receives Full AAHRPP Reaccreditation Following First Remote Site Visit During Pandemic
7/30/2020
Advarra IRB receives full accreditation with no findings, underscoring organizational commitment to high research ethics standards
-
Teleflex Announces Quarterly Dividend - July 30, 2020
7/30/2020
Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.
-
Teleflex Reports Second Quarter 2020 Results
7/30/2020
Second Quarter Revenues of $567.0 million, down 13.1% versus Prior Year Period; down 12.0% on a Constant Currency Basis
-
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
7/30/2020
More details of the three-month program will be provided in the near future.